{"schema_version":"1","generated_at":"2026-11-08T01:33:12.521Z","data_as_of":null,"url":"https://www.findmykol.com/kol/terri-parker","json_url":"https://www.findmykol.com/kol/terri-parker/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"terri-parker","name":"Terri Parker","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Yale University","institution_url":"https://www.findmykol.com/institution/yale-school-of-medicine","city":"New Haven","state":"CT","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1285825232","openalex":"A5112220269"},"summary":"Terri Parker is an Oncology physician affiliated with Yale University. OpenAlex indexes 77 publications with 2,012 citations (h-index 18); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":77,"cited_by_count":2012,"h_index":18,"latest_activity_year":2026,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT01465230","title":"Maintenance Therapy: Lenalidomide Following Bendamustine and Rituximab Induction Therapy for Chronic Lymphocytic Leukemia","phase":"PHASE2","status":"TERMINATED","role":"Overall official","sponsor":"Yale University","source_url":"https://clinicaltrials.gov/study/NCT01465230","trial_url":"https://www.findmykol.com/trial/NCT01465230"}],"source":"trials"},"payments":{"company_count":5,"program_years":{"first":2021,"last":null},"rows_total":26,"shown":3,"withheld":23,"rows":[{"payer":"Janssen","program_year":2025,"amount_usd":527279.9,"payment_count":45,"source_url":"https://openpaymentsdata.cms.gov/search?query=1285825232"},{"payer":"Takeda","program_year":2025,"amount_usd":3576,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1285825232"},{"payer":"Bristol Myers Squibb","program_year":2025,"amount_usd":2038.5,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1285825232"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1285825232","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Continuous or Fixed-Duration Maintenance Therapy in Multiple Myeloma","year":2026,"journal":"New England Journal of Medicine","source_url":"https://doi.org/10.1056/nejmoa2600157","status":"verified"},{"title":"GLP-1 RA Use and Major Adverse Cardiovascular Events in Patients With Monoclonal Gammopathy of Undetermined Significance","year":2025,"journal":"JAMA Network Open","source_url":"https://doi.org/10.1001/jamanetworkopen.2025.17541","status":"verified"},{"title":"Isatuximab for relapsed and/or refractory AL amyloidosis: results of a prospective phase 2 trial (SWOG S1702)","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood.2024027962","status":"verified"},{"title":"Teclistamab versus B-cell maturation antigen-targeting chimeric antigen receptor T-cell therapy in multiple myeloma: a comparative effectiveness analysis","year":2025,"journal":"Haematologica","source_url":"https://doi.org/10.3324/haematol.2024.287215","status":"verified"},{"title":"Carfilzomib or bortezomib with lenalidomide, and dexamethasone (VRd) for initial therapy of newly diagnosed multiple myeloma (NDMM): Long-term follow-up of the ECOG-ACRIN ENDURANCE phase 3 trial.","year":2025,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2025.43.16_suppl.7540","status":"verified"}],"source":"works"},"contact":{"address_1":"20 YORK ST","address_2":"YALE-NEW HAVEN HOSPITAL","city":"New Haven","state":"CT","zip":"065103220","phone":"203-200-4363","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1285825232","source":"identity"},"similar":[{"name":"John Krystal","slug":"john-krystal","institution":"Yale University","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/john-krystal","json_url":"https://www.findmykol.com/kol/john-krystal/profile.json"},{"name":"Lajos Pusztai","slug":"lajos-pusztai","institution":"Yale University","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/lajos-pusztai","json_url":"https://www.findmykol.com/kol/lajos-pusztai/profile.json"},{"name":"Lee Schwamm","slug":"lee-schwamm","institution":"Yale University","specialty":"Neurology","url":"https://www.findmykol.com/kol/lee-schwamm","json_url":"https://www.findmykol.com/kol/lee-schwamm/profile.json"},{"name":"Thomas McGlashan","slug":"thomas-mcglashan","institution":"Yale University","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/thomas-mcglashan","json_url":"https://www.findmykol.com/kol/thomas-mcglashan/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":23,"publications":45}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2012-07-17","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}